Skip to content

Author

Christophe Borg

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

EGFR Targeting With Afatinib and Cetuximab Versus Cetuximab Alone in Chemorefractory Wild-type RAS Metastatic Colorectal Cancer: A Randomized Phase II Study With Circulating Tumor Cell Analysis.

The combination of afatinib and cetuximab was ineffective in treating chemorefractory wtRAS mCRC, and associated with high toxicity, and associated with high toxicity.

V. Simmet, A. Lièvre, E. Samalin et al. · 0 citations
Open access Aug 2026

[Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives].

Anal canal squamous cell carcinoma (ASCC) is a rare tumor, predominantly caused by HPV16 infection, with a rising incidence, highlighting the importance of optimizing primary prevention, particularly through vaccination. While management of localized disease is well-established, treatment strategies for advanced stages...

Coralie Prevost, P. Vaflard, Cindy Neuzillet et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.